<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915939/" ref="ordinalpos=4542&amp;ncbi_uid=5793883&amp;link_uid=PMC3915939" image-link="/pmc/articles/PMC3915939/figure/F4/" class="imagepopup">Fig. 4.  From: EGFR(S) Inhibitors in the Treatment of Gastro-Intestinal Cancers: What's New?. </a></div><br /><div class="p4l_captionBody">Schematic representation of ligand induced activation of EGFR(s) signalling pathway. Ligand binding to the receptor results in dimerization and auto-/trans-phosphorylation that initiate the signaling cascade.</div></div>